Drug-induced thrombocytopenia

Current Opinion in Hematology

Volumn 6, Issue 5, 1999, Pages 349-353

  Rizvi, M A ^a   Shah, S R ^a   Raskob, G E ^a   George, J N ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; AMINOGLUTETHIMIDE; AMINOSALICYLIC ACID; AMIODARONE; AMPHOTERICIN B; CARBIMAZOLE; CD31 ANTIGEN; CIMETIDINE; COTRIMOXAZOLE; DANAZOL; DICLOFENAC; DIGOXIN; EPITOPE; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; L 739758; LEVAMISOLE; MECLOFENAMIC ACID; METHYLDOPA; N [(4 METHYLPHENYL)SULFONYL] 3 [[[5,6,7,8 TETRAHYDRO 4 OXO 5 [2 (4 PIPERIDINYL)ETHYL] 4H PYRAZOLO[1,5 A][1,4]DIAZEPIN 2 YL]CARBONYL]AMINO]ALANINE; NALIDIXIC ACID; OXPRENOLOL; PARACETAMOL; QUINIDINE; QUININE; RIFAMPICIN; SULFAMETHOXAZOLE; THROMBOCYTE ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIBODY COMBINING SITE; ANTIBODY DETECTION; DATA BASE; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

HUMAN; THROMBOCYTOPENIA;

EID: 0033302952     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199909000-00013     Document Type: Review

References (35)

1. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: Clinical and serological findings in nine patients and review of literature
2. Thrombotic thrombocytopenic purpura associated with ticlopidine-A review of 60 cases
3. Heparin-induced thrombocytopenia: Toward consensus
4. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia
5. Drug-induced immune thrombocytopenia: An overview of pathogenesis
6. Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: Characterization of the epitopes
7. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies
8. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex
9. Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibody to human platelets
10. Switched at birth: A new family for PECAM-1
11. PECAM-1 is a target glycoprotein in drug-induced immune thrombocytopenia
12. Platelet GPIIb-IIIa blockers
13. Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy
14. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization
15. Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs
16. Drug-induced thrombocytopenia: A systematic review of published case reports
17. Drug-induced thrombocytopenia: Clinical data on 309 cases and the effect of corticosteroid therapy
18. Pseudothrombocytopenia: A laboratory artifact with potentially serious consequences
19. Pseudoleukocytosis due to EDTA-induced platelet clumping
20. EDTA-dependent pseudothrombocytopaenia: A 12-month epidemiological study
21. EDTA-dependent pseudothrombocytopenia in ambulatory patients: Clinical characteristics and role of new automated cell-counting in its detection
22. Pseudo-thrombocytopenia in plateletpheresis donors
23. Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia
24. EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIb-IIIa
25. IgG platelet antibodies in EDTA-dependent pseudothrombocytopenia bind to platelet membrane glycoprotein IIb
26. Thrombocytopenia induced by Abciximab: Studies of pathogenesis
27. Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa
28. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
29. Detection of drug-dependent, platelet-reactive antibodies by solid-phase red cell adherence assays
30. Quinidine-induced thrombocytopenic purpura: Clinical presentation in relation to drug-dependent and drug-independent platelet antibodies
31. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: Platelet factor 4 complexes
32. The presence of antibodies against a PF4-heparin complex in patients on haemodialysis
33. Heparin-induced thrombocytopenia and thrombosis: A prospective analysis of the incidence in patients with heart and cerebrovascular diseases
34. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery
35. Acute thrombocytopenic purpura in relation to the use of drugs